)
Rossari Biotech (ROSSARI) investor relations material
Rossari Biotech Q2 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Q2 FY26 revenue grew 18% year-over-year to ₹586.1 crore, driven by strong volume expansion across HPPC, TSC, and AHN segments, despite subdued pricing and tariff headwinds.
Export revenues rose 36% year-over-year in Q2, now comprising 28% of total revenues, with growth in Far East, Southeast Asia, and MENA regions.
New product development and R&D, especially in green chemistry, have expanded the technology pipeline and product portfolio.
Unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025, were approved and reviewed by the Board and Audit Committee.
Statutory auditors conducted a limited review and found no material misstatements in the results.
Financial highlights
Q2 FY26 consolidated revenue: ₹5,861.07 million, up from ₹4,983.51 million in Q2 FY25; H1 revenue: ₹11,298.23 million, up from ₹9,880.01 million year-over-year.
Q2 FY26 EBITDA: ₹71.9 crore, margin at 12.3% (down from 13.2% last year); PAT: ₹36.9 crore, margin at 6.3%.
Standalone Q2 FY26 revenue: ₹4,195.12 million, up from ₹3,359.89 million in Q2 FY25; standalone PAT: ₹312.49 million, up from ₹262.33 million.
Net working capital increased to 102 days (from 95 days in March) due to stretched receivables and strategic inventory stocking.
CapEx outlay of ₹192 crore, with most projects to be commissioned in the coming months.
Outlook and guidance
Management remains optimistic about sustaining healthy growth momentum in FY27, supported by new capacities and robust product pipeline.
Margin guidance for core B2B business remains at 14–16% EBITDA for H2 FY26.
Margin expansion expected mainly in FY27 as new capacities reach optimal utilization.
Additional investment of up to USD 8 million approved for the Saudi Arabia subsidiary to support business expansion, to be completed by March 31, 2027.
Next Rossari Biotech earnings date
Next Rossari Biotech earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)